CLINICAL_TRIALS
trial_result
· 2020-05-07
Clinical Trial Update: Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) [Phase 2]
Summary
Phase 2 clinical trial update evaluating dupilumab and immune responses in adults with atopic dermatitis. Results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-05-07